China Shineway Pharmaceutical Group Limited 每股年股息為 0.4932,收益率為 0.00%。股息每 每季度 支付,最後除權日為 Sep 9, 2025。
股息收益率
年度股息
除息日
0.00%
$0.4932
Sep 9, 2025
付款頻率
派息比例
每季度
0.00%
股利歷史
除息日
現金金額
記錄日期
付款日
Sep 9, 2025
$0.12
Sep 10, 2025
Sep 26, 2025
Apr 30, 2025
$0.385
May 2, 2025
May 20, 2025
Sep 10, 2024
$0.12
Sep 11, 2024
Sep 27, 2024
Apr 29, 2024
$0.461
Apr 30, 2024
May 17, 2024
Apr 29, 2024
$0.461
Apr 30, 2024
May 17, 2024
Sep 12, 2023
$0.118
Sep 13, 2023
Sep 29, 2023
股利圖表
CSWYF 股利
CSWYF 股息增長(年增率)
Follow-Up Questions
China Shineway Pharmaceutical Group Limited 當前的股息支付和年度股息是多少?
China Shineway Pharmaceutical Group Limited 的股息支付比率是多少?
CSWYF 的除息日是什麼?
China Shineway Pharmaceutical Group Limited 多久支付一次股息?
關鍵數據
前收市價
$1
開盤價
$1
當日範圍
$0.9253 - $1.08
52週區間
$0.9253 - $1.08
交易量
100
平均成交量
0
每股盈餘 (TTM)
0.21
股息收益率
--
市值
$815.8M
什麼是 CHINA SHINEWAY PHARMACEUTICAL G?
China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 2,867 full-time employees. The company went IPO on 2004-12-02. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The firm operates its business in mainland China and Hong Kong markets.